Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment

Diab Vasc Dis Res. 2012 Apr;9(2):85-8. doi: 10.1177/1479164112441527.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic / legislation & jurisprudence
  • Comorbidity
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality
  • Drug Approval
  • Evidence-Based Medicine
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Patient Safety* / legislation & jurisprudence
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Hypoglycemic Agents